{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,4]],"date-time":"2026-09-04T09:34:19Z","timestamp":1788514459892,"version":"build-2803163510"},"reference-count":51,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2024,11,11]],"date-time":"2024-11-11T00:00:00Z","timestamp":1731283200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"},{"start":{"date-parts":[[2024,11,11]],"date-time":"2024-11-11T00:00:00Z","timestamp":1731283200000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"}],"funder":[{"DOI":"10.13039\/501100001691","name":"Japan Society for the Promotion of Science, KAKENHI","doi-asserted-by":"crossref","award":["JP21K16324"],"award-info":[{"award-number":["JP21K16324"]}],"id":[{"id":"10.13039\/501100001691","id-type":"DOI","asserted-by":"crossref"}]},{"name":"Kobayashi Foundation","award":["Kobayashi pharmacy-related grant"],"award-info":[{"award-number":["Kobayashi pharmacy-related grant"]}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Sci Rep"],"DOI":"10.1038\/s41598-024-78815-3","type":"journal-article","created":{"date-parts":[[2024,11,11]],"date-time":"2024-11-11T05:47:52Z","timestamp":1731304072000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":9,"title":["Diverse antifungal potency of terbinafine as a therapeutic agent against Exophiala dermatitidis in vitro"],"prefix":"10.1038","volume":"14","author":[{"given":"Tomofumi","family":"Nakamura","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Tatsuya","family":"Yoshinouchi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mayu","family":"Okumura","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Toshiro","family":"Yokoyama","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Daisuke","family":"Mori","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hirotomo","family":"Nakata","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jun-ichirou","family":"Yasunaga","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yasuhito","family":"Tanaka","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2024,11,11]]},"reference":[{"key":"78815_CR1","doi-asserted-by":"publisher","first-page":"57","DOI":"10.3390\/jof3040057","volume":"3","author":"F Bongomin","year":"2017","unstructured":"Bongomin, F., Gago, S., Oladele, R. O. & Denning, D. W. Global and multi-national prevalence of fungal diseases-estimate precision. J. Fungi 3, 57 (2017).","journal-title":"J. Fungi"},{"key":"78815_CR2","doi-asserted-by":"publisher","first-page":"165rv13","DOI":"10.1126\/scitranslmed.3004404","volume":"4","author":"GD Brown","year":"2012","unstructured":"Brown, G. D. et al. Hidden killers: human fungal infections. Sci. Transl. Med. 4, 165rv13 (2012).","journal-title":"Sci. Transl. Med."},{"key":"78815_CR3","doi-asserted-by":"publisher","first-page":"493","DOI":"10.3109\/13693786.2012.738313","volume":"51","author":"A D\u00f6\u011fen","year":"2013","unstructured":"D\u00f6\u011fen, A. et al. Dishwashers are a major source of human opportunistic yeast-like fungi in indoor environments in Mersin, Turkey. Med. Mycol. 51, 493\u2013498 (2013).","journal-title":"Med. Mycol."},{"key":"78815_CR4","doi-asserted-by":"publisher","first-page":"425","DOI":"10.1016\/j.clindermatol.2011.09.015","volume":"30","author":"R Isa-Isa","year":"2012","unstructured":"Isa-Isa, R., Garc\u00eda, C., Isa, M. & Arenas, R. Subcutaneous phaeohyphomycosis (mycotic cyst). Clin. Dermatol. 30, 425\u2013431 (2012).","journal-title":"Clin. Dermatol."},{"key":"78815_CR5","doi-asserted-by":"publisher","first-page":"S4","DOI":"10.3109\/13693786.2010.495731","volume":"48","author":"P Lebecque","year":"2010","unstructured":"Lebecque, P. et al. Exophiala (Wangiella) dermatitidis and cystic fibrosis prevalence and risk factors. Med. Mycol. 48, S4-9 (2010).","journal-title":"Med. Mycol."},{"key":"78815_CR6","doi-asserted-by":"publisher","first-page":"959","DOI":"10.1093\/cid\/cix948","volume":"66","author":"A Vasquez","year":"2018","unstructured":"Vasquez, A. et al. Management of an outbreak of Exophiala dermatitidis bloodstream infections at an outpatient oncology clinic. Clin. Infect. Dis. 66, 959\u2013962 (2018).","journal-title":"Clin. Infect. Dis."},{"key":"78815_CR7","first-page":"984","volume-title":"Virulence","author":"L Kirchhoff","year":"2019","unstructured":"Kirchhoff, L., Olsowski, M., Rath, P. M. & Steinmann, J. Exophiala dermatitidis: Key issues of an opportunistic fungal pathogen. In Virulence 984\u2013998 (Taylor and Francis Inc, 2019)."},{"key":"78815_CR8","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1093\/femsle\/fnu016","volume":"362","author":"N Kondori","year":"2015","unstructured":"Kondori, N. et al. Analyses of black fungi by matrix-assisted laser desorption\/ionization time-of-flight mass spectrometry (MALDI-TOF MS): species-level identification of clinical isolates of Exophiala dermatitidis. FEMS Microbiol. Lett. 362, 1\u20136 (2015).","journal-title":"FEMS Microbiol. Lett."},{"key":"78815_CR9","doi-asserted-by":"publisher","first-page":"100617","DOI":"10.1016\/j.mmcr.2023.100617","volume":"42","author":"T Yoshinouchi","year":"2023","unstructured":"Yoshinouchi, T. et al. Diagnosis and clinical management of Exophiala dermatitidis pneumonia in a patient with anorexia nervosa: A case report. Med. Mycol. Case Rep. 42, 100617 (2023).","journal-title":"Med. Mycol. Case Rep."},{"key":"78815_CR10","doi-asserted-by":"publisher","first-page":"482","DOI":"10.1186\/s12887-022-03518-5","volume":"22","author":"A Mpakosi","year":"2022","unstructured":"Mpakosi, A. et al. A fatal neonatal case of fungemia due to Exophiala dermatitidis-case report and literature review. BMC Pediatr. 22, 482 (2022).","journal-title":"BMC Pediatr."},{"key":"78815_CR11","doi-asserted-by":"publisher","first-page":"328","DOI":"10.1111\/myc.12597","volume":"60","author":"WC Silva","year":"2017","unstructured":"Silva, W. C. et al. Species diversity, antifungal susceptibility and phenotypic and genotypic characterisation of Exophiala spp. infecting patients in different medical centres in Brazil. Mycoses 60, 328\u2013337 (2017).","journal-title":"Mycoses"},{"key":"78815_CR12","doi-asserted-by":"publisher","first-page":"1239","DOI":"10.1126\/science.6547247","volume":"224","author":"G Petranyi","year":"1984","unstructured":"Petranyi, G., Ryder, N. S. & St\u00fctz, A. Allylamine derivatives: new class of synthetic antifungal agents inhibiting fungal squalene epoxidase. Science 224, 1239\u20131241 (1984).","journal-title":"Science"},{"key":"78815_CR13","doi-asserted-by":"publisher","first-page":"104240","DOI":"10.1016\/j.bioorg.2020.104240","volume":"104","author":"M Shafiei","year":"2020","unstructured":"Shafiei, M., Peyton, L., Hashemzadeh, M. & Foroumadi, A. History of the development of antifungal azoles: A review on structures, SAR, and mechanism of action. Bioorg. Chem. 104, 104240 (2020).","journal-title":"Bioorg. Chem."},{"key":"78815_CR14","doi-asserted-by":"publisher","first-page":"ii3","DOI":"10.1093\/jac\/dkac351","volume":"77","author":"RJ Br\u00fcggemann","year":"2022","unstructured":"Br\u00fcggemann, R. J., Jensen, G. M. & Lass-Fl\u00f6rl, C. Liposomal amphotericin B-the past. J. Antimicrob. Chemother. 77, ii3\u2013ii10 (2022).","journal-title":"J. Antimicrob. Chemother."},{"key":"78815_CR15","doi-asserted-by":"publisher","first-page":"1","DOI":"10.3314\/mmj.21-00012","volume":"63","author":"Y Alimu","year":"2022","unstructured":"Alimu, Y., Ban, S. & Yaguchi, T. Molecular phylogenetic study of strains morphologically identified as Exophiala dermatitidis from clinical and environmental specimens in Japan. Med. Mycol. J. 63, 1\u20139 (2022).","journal-title":"Med. Mycol. J."},{"key":"78815_CR16","doi-asserted-by":"publisher","first-page":"245","DOI":"10.3314\/jjmm1960.27.245","volume":"27","author":"W Naka","year":"1986","unstructured":"Naka, W., Harada, T. & Nishikawa, T. Growth temperature of pathogenic dematiaceous fungi and skin surface temperature. Jpn. J. Med. Mycol. 27, 245\u2013250 (1986).","journal-title":"Jpn. J. Med. Mycol."},{"key":"78815_CR17","doi-asserted-by":"publisher","first-page":"252","DOI":"10.1128\/AAC.27.2.252","volume":"27","author":"NS Ryder","year":"1985","unstructured":"Ryder, N. S. Specific inhibition of fungal sterol biosynthesis by SF 86\u2013327, a new allylamine antimycotic agent. Antimicrob. Agents Chemother. 27, 252\u2013256 (1985).","journal-title":"Antimicrob. Agents Chemother."},{"key":"78815_CR18","doi-asserted-by":"publisher","first-page":"97","DOI":"10.1038\/s41467-018-07928-x","volume":"10","author":"AK Padyana","year":"2019","unstructured":"Padyana, A. K. et al. Structure and inhibition mechanism of the catalytic domain of human squalene epoxidase. Nat. Commun. 10, 97 (2019).","journal-title":"Nat. Commun."},{"key":"78815_CR19","doi-asserted-by":"publisher","first-page":"501","DOI":"10.1128\/CMR.12.4.501","volume":"12","author":"MA Ghannoum","year":"1999","unstructured":"Ghannoum, M. A. & Rice, L. B. Antifungal agents: mode of action, mechanisms of resistance, and correlation of these mechanisms with bacterial resistance. Clin. Microbiol. Rev. 12, 501\u2013517 (1999).","journal-title":"Clin. Microbiol. Rev."},{"key":"78815_CR20","first-page":"e48819","volume":"15","author":"SHT Ramzi","year":"2023","unstructured":"Ramzi, S. H. T. et al. Efficacy of terbinafine and itraconazole combination therapy versus terbinafine or itraconazole monotherapy in the management of fungal diseases: A systematic review and meta-analysis. Cureus 15, e48819 (2023).","journal-title":"Cureus"},{"key":"78815_CR21","first-page":"1299","volume":"4","author":"M Ishiyama","year":"1994","unstructured":"Ishiyama, M., Miyazono, Y., Sasamoto, K., Ohkura, Y. & Ueno, K. A highly water-soluble disulfonated tetrazolium salt as a chromogenic indicator for NADH as well as cell viability. Talanta 4, 1299\u20131305 (1994).","journal-title":"Talanta"},{"key":"78815_CR22","doi-asserted-by":"publisher","first-page":"111","DOI":"10.1007\/s11046-010-9358-6","volume":"171","author":"Y Sun","year":"2011","unstructured":"Sun, Y., Liu, W., Wan, Z., Wang, X. & Li, R. Antifungal activity of antifungal drugs, as well as drug combinations against Exophiala dermatitidis. Mycopathologia 171, 111\u2013117 (2011).","journal-title":"Mycopathologia"},{"key":"78815_CR23","doi-asserted-by":"publisher","first-page":"819","DOI":"10.3109\/13693786.2011.583285","volume":"49","author":"H Badali","year":"2011","unstructured":"Badali, H., de Hoog, G. S., Sudhadham, M. & Meis, J. F. Microdilution in vitro antifungal susceptibility of Exophiala dermatitidis, a systemic opportunist. Med. Mycol. 49, 819\u2013824 (2011).","journal-title":"Med. Mycol."},{"key":"78815_CR24","doi-asserted-by":"publisher","first-page":"1614","DOI":"10.3390\/microorganisms11061614","volume":"11","author":"S Sharma","year":"2023","unstructured":"Sharma, S. et al. Microbial biofilm: A review on formation, infection, antibiotic resistance, control measures, and innovative treatment. Microorganisms 11, 1614 (2023).","journal-title":"Microorganisms"},{"key":"78815_CR25","doi-asserted-by":"publisher","first-page":"42886","DOI":"10.1038\/srep42886","volume":"7","author":"L Kirchhoff","year":"2017","unstructured":"Kirchhoff, L. et al. Biofilm formation of the black yeast-like fungus Exophiala dermatitidis and its susceptibility to antiinfective agents. Sci. Rep. 7, 42886 (2017).","journal-title":"Sci. Rep."},{"key":"78815_CR26","doi-asserted-by":"publisher","first-page":"268","DOI":"10.1128\/CMR.17.2.268-280.2004","volume":"17","author":"MA Pfaller","year":"2004","unstructured":"Pfaller, M. A., Sheehan, D. J. & Rex, J. H. Determination of fungicidal activities against yeasts and molds: lessons learned from bactericidal testing and the need for standardization. Clin. Microbiol. Rev. 17, 268\u2013280 (2004).","journal-title":"Clin. Microbiol. Rev."},{"key":"78815_CR27","doi-asserted-by":"publisher","first-page":"301","DOI":"10.1080\/13693780310001600822","volume":"41","author":"RG Vitale","year":"2003","unstructured":"Vitale, R. G., De Hoog, G. S. & Verweij, P. E. In vitro activity of amphotericin B, itraconazole, terbinafine and 5-fluocytosine against Exophiala spinifera and evaluation of post-antifungal effects. Med. Mycol. 41, 301\u2013307 (2003).","journal-title":"Med. Mycol."},{"key":"78815_CR28","doi-asserted-by":"publisher","first-page":"S37","DOI":"10.1016\/S0190-9622(98)70482-7","volume":"38","author":"KC Hazen","year":"1998","unstructured":"Hazen, K. C. Fungicidal versus fungistatic activity of terbinafine and itraconazole: an in vitro comparison. J. Am. Acad. Dermatol. 38, S37-41 (1998).","journal-title":"J. Am. Acad. Dermatol."},{"key":"78815_CR29","doi-asserted-by":"publisher","first-page":"854","DOI":"10.1093\/jac\/dkh434","volume":"54","author":"M Cuenca-Estrella","year":"2004","unstructured":"Cuenca-Estrella, M. Combinations of antifungal agents in therapy- what value are they?. J. Antimicrob. Chemother. 54, 854\u2013869 (2004).","journal-title":"J. Antimicrob. Chemother."},{"key":"78815_CR30","doi-asserted-by":"publisher","first-page":"106","DOI":"10.1128\/AAC.47.1.106-117.2003","volume":"47","author":"J Meletiadis","year":"2003","unstructured":"Meletiadis, J., Mouton, J. W., Meis, J. F. & Verweij, P. E. In vitro drug interaction modeling of combinations of azoles with terbinafine against clinical Scedosporium prolificans isolates. Antimicrob. Agents Chemother. 47, 106\u2013117 (2003).","journal-title":"Antimicrob. Agents Chemother."},{"key":"78815_CR31","doi-asserted-by":"publisher","first-page":"353","DOI":"10.1001\/archderm.138.3.353","volume":"138","author":"B Sigurgeirsson","year":"2002","unstructured":"Sigurgeirsson, B. et al. Long-term effectiveness of treatment with terbinafine vs itraconazole in onychomycosis: a 5-year blinded prospective follow-up study. Arch. Dermatol. 138, 353\u2013357 (2002).","journal-title":"Arch. Dermatol."},{"key":"78815_CR32","doi-asserted-by":"publisher","first-page":"e00115","DOI":"10.1128\/AAC.00115-17","volume":"61","author":"T Yamada","year":"2017","unstructured":"Yamada, T. et al. Terbinafine resistance of trichophyton clinical isolates caused by specific point mutations in the squalene epoxidase gene. Antimicrob. Agents Chemother. 61, e00115-e117 (2017).","journal-title":"Antimicrob. Agents Chemother."},{"key":"78815_CR33","doi-asserted-by":"publisher","first-page":"510","DOI":"10.1111\/jvp.12942","volume":"44","author":"C Rojo-Sol\u00eds","year":"2021","unstructured":"Rojo-Sol\u00eds, C. et al. Pharmacokinetics of single dose oral terbinafine in common Shelducks (Tadorna tadorna). J. Vet. Pharmacol. Ther. 44, 510\u2013515 (2021).","journal-title":"J. Vet. Pharmacol. Ther."},{"key":"78815_CR34","doi-asserted-by":"publisher","first-page":"S42","DOI":"10.1016\/S0190-9622(98)70483-9","volume":"38","author":"J Leyden","year":"1998","unstructured":"Leyden, J. Pharmacokinetics and pharmacology of terbinafine and itraconazole. J. Am. Acad. Dermatol. 38, S42\u2013S47 (1998).","journal-title":"J. Am. Acad. Dermatol."},{"key":"78815_CR35","doi-asserted-by":"publisher","first-page":"121","DOI":"10.1111\/j.1365-2230.1994.tb01138.x","volume":"19","author":"J Faergemann","year":"1994","unstructured":"Faergemann, J., Zehender, H. & Millerioux, L. Levels of terbinafine in plasma, stratum corneum, dermis-epidermis (without stratum corneum), sebum, hair and nails during and after 250 mg terbinafine orally once daily for 7 and 14 days. Clin. Exp. Dermatol. 19, 121\u2013126 (1994).","journal-title":"Clin. Exp. Dermatol."},{"key":"78815_CR36","doi-asserted-by":"publisher","first-page":"122","DOI":"10.1647\/2008-052.1","volume":"24","author":"U Bechert","year":"2010","unstructured":"Bechert, U., Christensen, J. M., Poppenga, R., Fahmy, S. A. & Redig, P. Pharmacokinetics of terbinafine after single oral dose administration in red-tailed hawks (Buteo jamaicensis). J. Avian Med. Surg. 24, 122\u2013130 (2010).","journal-title":"J. Avian Med. Surg."},{"key":"78815_CR37","doi-asserted-by":"publisher","first-page":"832","DOI":"10.1007\/BF01967386","volume":"9","author":"HJ Schmitt","year":"1990","unstructured":"Schmitt, H. J. et al. Inactivity of terbinafine in a rat model of pulmonary aspergillosis. Eur. J. Clin. Microbiol. Infect. Dis. 9, 832\u2013835 (1990).","journal-title":"Eur. J. Clin. Microbiol. Infect. Dis."},{"key":"78815_CR38","first-page":"47","volume":"1","author":"GF Schiraldi","year":"2016","unstructured":"Schiraldi, G. F. et al. Terbinafine versus itraconazole: a long-term, randomized, double-blind, clinical trial in chronic pulmonary aspergillosis. A pilote study. J. Health Soc. Sci. 1, 47\u201356 (2016).","journal-title":"J. Health Soc. Sci."},{"key":"78815_CR39","doi-asserted-by":"publisher","first-page":"25","DOI":"10.1111\/j.1365-2133.1996.tb15656.x","volume":"134","author":"GF Schiraldi","year":"1996","unstructured":"Schiraldi, G. F. et al. Refractory pulmonary aspergillosis: compassionate trial with terbinafine. Br. J. Dermatol. 134, 25\u201329 (1996).","journal-title":"Br. J. Dermatol."},{"key":"78815_CR40","doi-asserted-by":"publisher","first-page":"4941","DOI":"10.1128\/AAC.03252-14","volume":"58","author":"O Blennow","year":"2014","unstructured":"Blennow, O. et al. Posaconazole concentrations in human tissues after allogeneic stem cell transplantation. Antimicrob. Agents Chemother. 58, 4941\u20134943 (2014).","journal-title":"Antimicrob. Agents Chemother."},{"key":"78815_CR41","doi-asserted-by":"publisher","first-page":"188","DOI":"10.1080\/08998280.2007.11928283","volume":"20","author":"ND Greer","year":"2007","unstructured":"Greer, N. D. Posaconazole (noxafil): a new triazole antifungal agent. Bayl. Univ. Med. Cent. Proc. 20, 188\u2013196 (2007).","journal-title":"Bayl. Univ. Med. Cent. Proc."},{"key":"78815_CR42","doi-asserted-by":"publisher","first-page":"4096","DOI":"10.1128\/AAC.00630-06","volume":"50","author":"JW Mouton","year":"2006","unstructured":"Mouton, J. W. et al. Pharmacokinetics of itraconazole and hydroxyitraconazole in healthy subjects after single and multiple doses of a novel formulation. Antimicrob. Agents Chemother. 50, 4096\u20134102 (2006).","journal-title":"Antimicrob. Agents Chemother."},{"key":"78815_CR43","doi-asserted-by":"publisher","first-page":"915","DOI":"10.3389\/fmicb.2018.00915","volume":"9","author":"J Zhang","year":"2018","unstructured":"Zhang, J. et al. Amikacin liposome inhalation suspension (ALIS) penetrates non-tuberculous mycobacterial biofilms and enhances amikacin uptake into macrophages. Front. Microbiol. 9, 915 (2018).","journal-title":"Front. Microbiol."},{"key":"78815_CR44","doi-asserted-by":"publisher","first-page":"1559","DOI":"10.1164\/rccm.201807-1318OC","volume":"198","author":"DE Griffith","year":"2018","unstructured":"Griffith, D. E. et al. Amikacin liposome inhalation suspension for treatment-refractory lung disease caused by Mycobacterium avium Complex (CONVERT). A prospective, open-label, randomized study. Am. J. Respir. Crit. Care Med. 198, 1559\u20131569 (2018).","journal-title":"Am. J. Respir. Crit. Care Med."},{"key":"78815_CR45","doi-asserted-by":"publisher","first-page":"87","DOI":"10.3390\/pharmaceutics14010087","volume":"14","author":"K Almansour","year":"2021","unstructured":"Almansour, K. et al. Inhalable, spray-dried terbinafine microparticles for management of pulmonary fungal infections: optimization of the excipient composition and selection of an inhalation device. Pharmaceutics 14, 87 (2021).","journal-title":"Pharmaceutics"},{"key":"78815_CR46","doi-asserted-by":"publisher","first-page":"641","DOI":"10.3390\/pharmaceutics14030641","volume":"14","author":"K Brunet","year":"2022","unstructured":"Brunet, K., Martellosio, J. P., Tewes, F., Marchand, S. & Rammaert, B. Inhaled antifungal agents for treatment and prophylaxis of bronchopulmonary invasive mold infections. Pharmaceutics 14, 641 (2022).","journal-title":"Pharmaceutics"},{"key":"78815_CR47","doi-asserted-by":"publisher","first-page":"122788","DOI":"10.1016\/j.ijpharm.2023.122788","volume":"635","author":"E de Pablo","year":"2023","unstructured":"de Pablo, E. et al. Targeting lung macrophages for fungal and parasitic pulmonary infections with innovative amphotericin B dry powder inhalers. Int. J. Pharm. 635, 122788 (2023).","journal-title":"Int. J. Pharm."},{"key":"78815_CR48","doi-asserted-by":"publisher","first-page":"pgad446","DOI":"10.1093\/pnasnexus\/pgad446","volume":"3","author":"T Nakamura","year":"2023","unstructured":"Nakamura, T. et al. Conversion of raltegravir carrying a 1,3,4-oxadiazole ring to a hydrolysis product upon pH changes decreases its antiviral activity. PNAS Nexus 3, pgad446 (2023).","journal-title":"PNAS Nexus"},{"key":"78815_CR49","doi-asserted-by":"publisher","first-page":"5","DOI":"10.3314\/mmj.18-00011","volume":"60","author":"T Ichikawa","year":"2019","unstructured":"Ichikawa, T. et al. Adherence and cytotoxicity of Candida spp. to HaCaT and A549 cells. Med. Mycol. J. 60, 5\u201310 (2019).","journal-title":"Med. Mycol. J."},{"key":"78815_CR50","doi-asserted-by":"publisher","first-page":"1494","DOI":"10.1038\/nprot.2008.141","volume":"3","author":"CG Pierce","year":"2008","unstructured":"Pierce, C. G. et al. A simple and reproducible 96-well plate-based method for the formation of fungal biofilms and its application to antifungal susceptibility testing. Nat. Protoc. 3, 1494\u20131500 (2008).","journal-title":"Nat. Protoc."},{"key":"78815_CR51","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1093\/jac\/dkg301","volume":"52","author":"FC Odds","year":"2003","unstructured":"Odds, F. C. Synergy, antagonism, and what the chequerboard puts between them. J. Antimicrob. Chemother. 52, 1 (2003).","journal-title":"J. Antimicrob. Chemother."}],"container-title":["Scientific Reports"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.nature.com\/articles\/s41598-024-78815-3.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s41598-024-78815-3","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s41598-024-78815-3.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2024,11,11]],"date-time":"2024-11-11T07:02:48Z","timestamp":1731308568000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.nature.com\/articles\/s41598-024-78815-3"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2024,11,11]]},"references-count":51,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2024,12]]}},"alternative-id":["78815"],"URL":"https:\/\/doi.org\/10.1038\/s41598-024-78815-3","relation":{},"ISSN":["2045-2322"],"issn-type":[{"value":"2045-2322","type":"electronic"}],"subject":[],"published":{"date-parts":[[2024,11,11]]},"assertion":[{"value":"24 June 2024","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"4 November 2024","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"11 November 2024","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"The authors declare no competing interests.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}],"article-number":"27500"}}